Biotricity Begin Period Cash Flow vs Sale Purchase Of Stock Analysis

BTCY Stock

USD 1.19 0.02 1.65%

Biotricity financial indicator trend analysis is way more than just evaluating Biotricity prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biotricity is a good investment. Please check the relationship between Biotricity Begin Period Cash Flow and its Sale Purchase Of Stock accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotricity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.

Begin Period Cash Flow vs Sale Purchase Of Stock

Begin Period Cash Flow vs Sale Purchase Of Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biotricity Begin Period Cash Flow account and Sale Purchase Of Stock. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Biotricity's Begin Period Cash Flow and Sale Purchase Of Stock is -0.59. Overlapping area represents the amount of variation of Begin Period Cash Flow that can explain the historical movement of Sale Purchase Of Stock in the same time period over historical financial statements of Biotricity, assuming nothing else is changed. The correlation between historical values of Biotricity's Begin Period Cash Flow and Sale Purchase Of Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Begin Period Cash Flow of Biotricity are associated (or correlated) with its Sale Purchase Of Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Sale Purchase Of Stock has no effect on the direction of Begin Period Cash Flow i.e., Biotricity's Begin Period Cash Flow and Sale Purchase Of Stock go up and down completely randomly.

Correlation Coefficient

-0.59

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Sale Purchase Of Stock

Most indicators from Biotricity's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biotricity current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotricity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.At this time, Biotricity's Selling General Administrative is fairly stable compared to the past year. Enterprise Value is likely to rise to about 11.4 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 2.2 M in 2024.

Biotricity fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Tangible Assets	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Short Term Investments	Inventory
Total Assets		0.78	0.2	0.6	-0.49	0.61	0.53	-0.81	0.57	0.82	0.82	0.89	0.58	0.28	0.8	0.79	0.76	0.97	0.57	0.7	-0.3	0.76	0.83	0.75	0.68	0.62
Short Long Term Debt Total	0.78		0.24	0.88	-0.9	0.72	0.94	-0.93	0.95	0.3	0.3	0.9	0.6	0.34	0.99	0.92	0.99	0.62	0.88	0.74	-0.26	0.99	0.87	0.78	0.97	0.97
Other Current Liab	0.2	0.24		0.63	-0.4	0.38	0.23	-0.4	0.31	0.06	0.06	0.44	0.53	0.1	0.17	0.38	0.35	0.2	0.56	0.46	-0.92	0.14	0.25	0.2	0.35	0.2
Total Current Liabilities	0.6	0.88	0.63		-0.93	0.77	0.88	-0.9	0.92	0.1	0.1	0.87	0.7	0.31	0.82	0.88	0.93	0.44	0.99	0.77	-0.62	0.83	0.74	0.69	0.94	0.87
Total Stockholder Equity	-0.49	-0.9	-0.4	-0.93		-0.67	-0.97	0.85	-0.97	0.07	0.07	-0.75	-0.58	-0.3	-0.86	-0.82	-0.93	-0.31	-0.94	-0.69	0.38	-0.89	-0.75	-0.68	-0.95	-0.95
Current Deferred Revenue	0.61	0.72	0.38	0.77	-0.67		0.65	-0.88	0.76	0.26	0.26	0.77	0.9	0.33	0.68	0.91	0.75	0.5	0.81	0.89	-0.49	0.69	0.62	0.7	0.75	0.67
Net Debt	0.53	0.94	0.23	0.88	-0.97	0.65		-0.83	0.98	-0.04	-0.04	0.75	0.49	0.3	0.92	0.82	0.95	0.33	0.9	0.63	-0.21	0.94	0.75	0.66	0.96	0.99
Retained Earnings	-0.81	-0.93	-0.4	-0.9	0.85	-0.88	-0.83		-0.89	-0.4	-0.4	-0.94	-0.82	-0.37	-0.9	-0.97	-0.94	-0.7	-0.9	-0.91	0.48	-0.9	-0.87	-0.86	-0.92	-0.86
Accounts Payable	0.57	0.95	0.31	0.92	-0.97	0.76	0.98	-0.89		0.02	0.02	0.79	0.63	0.32	0.92	0.89	0.96	0.38	0.94	0.74	-0.32	0.94	0.75	0.72	0.96	0.98
Cash	0.82	0.3	0.06	0.1	0.07	0.26	-0.04	-0.4	0.02		1.0	0.53	0.33	0.12	0.35	0.38	0.26	0.92	0.05	0.39	-0.18	0.27	0.48	0.43	0.15	0.07
Cash And Short Term Investments	0.82	0.3	0.06	0.1	0.07	0.26	-0.04	-0.4	0.02	1.0		0.53	0.33	0.12	0.35	0.38	0.26	0.92	0.05	0.39	-0.18	0.27	0.48	0.43	0.15	0.07
Net Receivables	0.89	0.9	0.44	0.87	-0.75	0.77	0.75	-0.94	0.79	0.53	0.53		0.7	0.33	0.86	0.9	0.91	0.8	0.85	0.8	-0.51	0.86	0.86	0.8	0.9	0.8
Common Stock Total Equity	0.58	0.6	0.53	0.7	-0.58	0.9	0.49	-0.82	0.63	0.33	0.33	0.7		0.49	0.58	0.82	0.64	0.55	0.71	0.97	-0.63	0.56	0.64	0.72	0.61	0.52
Common Stock Shares Outstanding	0.28	0.34	0.1	0.31	-0.3	0.33	0.3	-0.37	0.32	0.12	0.12	0.33	0.49		0.33	0.35	0.34	0.24	0.32	0.49	-0.09	0.33	0.35	0.33	0.34	0.32
Non Current Liabilities Total	0.8	0.99	0.17	0.82	-0.86	0.68	0.92	-0.9	0.92	0.35	0.35	0.86	0.58	0.33		0.9	0.97	0.65	0.82	0.73	-0.2	0.99	0.87	0.76	0.92	0.95
Other Stockholder Equity	0.79	0.92	0.38	0.88	-0.82	0.91	0.82	-0.97	0.89	0.38	0.38	0.9	0.82	0.35	0.9		0.93	0.66	0.89	0.9	-0.44	0.89	0.81	0.79	0.89	0.86
Total Liab	0.76	0.99	0.35	0.93	-0.93	0.75	0.95	-0.94	0.96	0.26	0.26	0.91	0.64	0.34	0.97	0.93		0.6	0.93	0.77	-0.37	0.97	0.86	0.78	0.98	0.97
Total Current Assets	0.97	0.62	0.2	0.44	-0.31	0.5	0.33	-0.7	0.38	0.92	0.92	0.8	0.55	0.24	0.65	0.66	0.6		0.41	0.66	-0.3	0.59	0.78	0.7	0.5	0.43
Short Term Debt	0.57	0.88	0.56	0.99	-0.94	0.81	0.9	-0.9	0.94	0.05	0.05	0.85	0.71	0.32	0.82	0.89	0.93	0.41		0.77	-0.57	0.85	0.72	0.72	0.95	0.89
Common Stock	0.7	0.74	0.46	0.77	-0.69	0.89	0.63	-0.91	0.74	0.39	0.39	0.8	0.97	0.49	0.73	0.9	0.77	0.66	0.77		-0.55	0.71	0.8	0.83	0.73	0.66
Net Tangible Assets	-0.3	-0.26	-0.92	-0.62	0.38	-0.49	-0.21	0.48	-0.32	-0.18	-0.18	-0.51	-0.63	-0.09	-0.2	-0.44	-0.37	-0.3	-0.57	-0.55		-0.18	-0.27	-0.36	-0.36	-0.19
Non Current Assets Total	0.76	0.99	0.14	0.83	-0.89	0.69	0.94	-0.9	0.94	0.27	0.27	0.86	0.56	0.33	0.99	0.89	0.97	0.59	0.85	0.71	-0.18		0.86	0.79	0.95	0.97
Non Currrent Assets Other	0.83	0.87	0.25	0.74	-0.75	0.62	0.75	-0.87	0.75	0.48	0.48	0.86	0.64	0.35	0.87	0.81	0.86	0.78	0.72	0.8	-0.27	0.86		0.86	0.82	0.8
Other Assets	0.75	0.78	0.2	0.69	-0.68	0.7	0.66	-0.86	0.72	0.43	0.43	0.8	0.72	0.33	0.76	0.79	0.78	0.7	0.72	0.83	-0.36	0.79	0.86		0.75	0.7
Short Term Investments	0.68	0.97	0.35	0.94	-0.95	0.75	0.96	-0.92	0.96	0.15	0.15	0.9	0.61	0.34	0.92	0.89	0.98	0.5	0.95	0.73	-0.36	0.95	0.82	0.75		0.97
Inventory	0.62	0.97	0.2	0.87	-0.95	0.67	0.99	-0.86	0.98	0.07	0.07	0.8	0.52	0.32	0.95	0.86	0.97	0.43	0.89	0.66	-0.19	0.97	0.8	0.7	0.97

Click cells to compare fundamentals

Biotricity Account Relationship Matchups

Biotricity fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.0M	4.4M	16.7M	6.5M	7.5M	7.9M
Short Long Term Debt Total	2.3M	4.7M	15.4M	19.5M	22.5M	23.6M
Other Current Liab	427.6K	3.6M	520.7K	1.0M	1.2M	977.3K
Total Current Liabilities	3.8M	10.5M	4.9M	11.2M	12.8M	13.5M
Total Stockholder Equity	(3.0M)	(6.8M)	(2.1M)	(19.8M)	(17.9M)	(17.0M)
Net Debt	1.4M	2.5M	3.3M	19.0M	21.8M	22.9M
Retained Earnings	(46.4M)	(62.8M)	(93.0M)	(112.6M)	(101.3M)	(96.2M)
Accounts Payable	1.1M	1.0M	1.2M	3.4M	4.0M	4.1M
Cash	949.8K	2.2M	12.1M	570.5K	656.0K	623.2K
Cash And Short Term Investments	949.8K	2.2M	12.1M	570.5K	656.0K	623.2K
Net Receivables	623.3K	1.8M	2.4M	1.8M	2.1M	2.2M
Common Stock Total Equity	31.9K	35.4K	36.4K	39.0K	44.9K	27.8K
Common Stock Shares Outstanding	6.0M	6.3M	7.6M	8.7M	10.0M	7.3M
Liabilities And Stockholders Equity	2.0M	4.4M	16.7M	6.5M	7.5M	7.9M
Non Current Liabilities Total	1.2M	780.9K	14.0M	15.2M	17.5M	18.3M
Other Stockholder Equity	44.2M	56.6M	91.6M	92.8M	106.7M	112.1M
Total Liab	5.0M	11.3M	18.8M	26.4M	30.3M	31.8M
Total Current Assets	1.7M	4.3M	15.3M	4.7M	5.4M	3.2M
Accumulated Other Comprehensive Income	(857.3K)	(634.2K)	(768.7K)	(152.8K)	(137.5K)	(144.4K)
Short Term Debt	2.3M	4.3M	1.8M	5.1M	5.9M	6.2M
Common Stock	36.4K	39.0K	51.3K	52.5K	60.4K	33.8K
Net Tangible Assets	(1.8M)	(3.0M)	(6.8M)	(2.1M)	(1.9M)	(2.0M)
Non Current Assets Total	345.6K	116.5K	1.4M	1.8M	2.1M	2.2M
Short Term Investments	137.1K	326.7K	302.3K	588.6K	676.9K	710.7K
Inventory	85.7K	272.5K	842.9K	2.3M	2.7M	2.8M
Other Current Assets	137.1K	326.7K	406.3K	588.6K	676.9K	710.7K
Short Long Term Debt	2.1M	4.3M	1.5M	4.8M	5.5M	5.8M
Net Invested Capital	(932.1K)	(2.2M)	11.9M	(2.0M)	(2.3M)	(2.2M)
Net Working Capital	(2.1M)	(6.2M)	10.5M	(6.4M)	(5.8M)	(5.5M)
Capital Stock	36.4K	39.0K	51.3K	52.5K	60.4K	47.2K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

OEPIX	Oil Equipment Services
MMM	3M Company
SLV	iShares Silver Trust

When determining whether Biotricity offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biotricity's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biotricity Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biotricity Stock:

How To Invest In Biotricity

Details

Is Biotricity Stock a good investment?

Details

What is Biotricity's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotricity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.

Note that the Biotricity information on this page should be used as a complementary analysis to other Biotricity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Complementary Tools for Biotricity Stock analysis

When running Biotricity's price analysis, check to measure Biotricity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotricity is operating at the current time. Most of Biotricity's value examination focuses on studying past and present price action to predict the probability of Biotricity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotricity's price. Additionally, you may evaluate how the addition of Biotricity to your portfolios can decrease your overall portfolio volatility.

	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Commodity Channel Use Commodity Channel Index to analyze current equity momentum
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Transaction History View history of all your transactions and understand their impact on performance
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Equity Valuation Check real value of public entities based on technical and fundamental data
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets

Is Biotricity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biotricity. If investors know Biotricity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biotricity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.75)

Revenue Per Share

1.319

Quarterly Revenue Growth

0.209

Return On Assets

(0.95)

Return On Equity

(41.01)

The market value of Biotricity is measured differently than its book value, which is the value of Biotricity that is recorded on the company's balance sheet. Investors also form their own opinion of Biotricity's value that differs from its market value or its book value, called intrinsic value, which is Biotricity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biotricity's market value can be influenced by many factors that don't directly affect Biotricity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Biotricity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biotricity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biotricity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Biotricity Begin Period Cash Flow vs Sale Purchase Of Stock Analysis

Begin Period Cash Flow vs Sale Purchase Of Stock

Begin Period Cash Flow vs Sale Purchase Of Stock Correlation Analysis

Correlation Coefficient

Begin Period Cash Flow

Sale Purchase Of Stock

Biotricity fundamental ratios Correlations

Biotricity Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Biotricity fundamental ratios Accounts

Also Currently Popular

Complementary Tools for Biotricity Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Non Current Liabilities Total	+ 0.99	Short Long Term Debt Total
Total Liab	+ 0.99	Short Long Term Debt Total
Non Current Assets Total	+ 0.99	Short Long Term Debt Total
Short Term Debt	+ 0.99	Total Current Liabilities
Inventory	+ 0.99	Net Debt

Other Stockholder Equity	- 0.97	Retained Earnings
Accounts Payable	- 0.97	Total Stockholder Equity
Net Debt	- 0.97	Total Stockholder Equity
Inventory	- 0.95	Total Stockholder Equity
Short Term Investments	- 0.95	Total Stockholder Equity
Total Liab	- 0.94	Retained Earnings